Dayspring compression therapy system is now FDA cleared for treatment of lymphedema and venous diseases in both upper and lower extremities
Koya Medical strengthens leadership team with appointments of three industry veterans to support commercial expansion
OAKLAND, Calif., May 26, 2021 — Koya Medical, a healthcare company focused on developing breakthrough treatments for lymphedema and venous diseases, announced today that it has received Food and Drug Administration (FDA) 510(k) clearance for its active compression therapy system Dayspring™ for the treatment of lymphedema and venous diseases that impact lymphatic flow in lower extremities. The company also announced the appointments of three veteran executives to its leadership team to support commercialization: Rick Biro, Head of Sales; Liesl Oldstone, Head of Market Access and Clinical Affairs; and Damian Rippole, Chief…